Study on the optimal concentration of topical mitomycin-C in preventing postlaminectomy epidural adhesion.
There is increasing evidence that topical application of mitomycin-C can be beneficial in reducing epidural scar adhesion. However, the ideal concentration of mitomycin-C is unknown. The purpose of this study was to verify its efficacy for preventing epidural adhesion and the immediate electrophysiological responses caused by it in a laminectomy model. Seventy rats underwent laminectomy at L-1 and L-2. Cotton pads soaked with saline and various concentrations of mitomycin-C (0.1 mg/ml, 0.3 mg/ml, 0.5 mg/ml and 0.7 mg/ml) were applied to the exposed dura for 5 min. Spine somatosensory evoked potentials (SSEP) were monitored in preoperative and the immediate electrophysiological responses of mitomycin-C used. Four weeks postlaminectomy the rats were killed. The area of epidural scar tissue and degree of epidural adhesion were determined by 7.0 T Micro MR imaging. Macroscopic evaluations were performed according to the Rydell standard. The results showed that severe epidural adhesion was formed in the saline group and no dural adherence or incomplete adhesions were found in the mitomycin-C group. The Rydell classification and the degree of epidural adhesion and the area of the scar in 0.5 mg/ml group and 0.7 mg/ml mitomycin-C group revealed a significant decrease compared with the control group and 0.1 mg/ml group and 0.3 mg/ml mitomycin-C group. The spine sensory evoked potentials did not alter obviously in both preoperative and the immediate electrophysiological responses of mitomycin-C used. In conclusion, locally applied mitomycin-C in a concentration of 0.5 mg/ml and 0.7 mg/ml mitomycin-C may be the optimal concentration in preventing postlaminectomy epidural adhesion.
Su
Changhui
C
Department of Orthopedics Surgery, the First Affiliated Hospital of Nanjing Medical University, Guangzhou Road 300, Nanjing, 210029, Jiangsu Province, China.
Yao
Changjiang
C
Lu
Shenghua
S
Zhang
Ailiang
A
Cao
Xiaojian
X
Teng
Gaojun
G
Zang
Fengchao
F
D000287:Administration, Topical; D000818:Animals; D002921:Cicatrix / Q000175:diagnosis / Q000473:pathology; D004305:Dose-Response Relationship, Drug; D004824:Epidural Space / Q000187:drug effects / Q000473:pathology / Q000503:physiopathology; D005071:Evoked Potentials / Q000187:drug effects; D005355:Fibrosis; D007796:Laminectomy / Q000009:adverse effects*; D008279:Magnetic Resonance Imaging; D008297:Male; D016685:Mitomycin / Q000008:administration & dosage* / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley
D016685:Mitomycin